VitalStone Financial LLC purchased a new position in Charles River Laboratories International, Inc. (NYSE:CRL – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor purchased 1,857 shares of the medical research company’s stock, valued at approximately $439,000. Other hedge funds have also recently added to or reduced their stakes in the company. VisionPoint […]